National Cancer Institute; Notice of Closed Meetings, 10021-10022 [2017-02621]
Download as PDF
sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 82, No. 26 / Thursday, February 9, 2017 / Notices
Contact Person: David R. Jollie, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4166,
MSC 7806, Bethesda, MD 20892, (301) 437–
7927, jollieda@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Bacterial Pathogenesis.
Date: March 9, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Solamar, 435 6th Avenue, San
Diego, CA 92101.
Contact Person: Richard G. Kostriken,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192,
MSC 7808, Bethesda, MD 20892, 240–519–
7808, kostrikr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Biophysical, Physiological,
Pharmacological and Bioengineering
Neuroscience.
Date: March 9–10, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street NW., Washington, DC 20037.
Contact Person: Paula Elyse Schauwecker,
Ph.D., Scientific Review Officer, National
Institutes of Health, Center for Scientific
Review, 6701 Rockledge Drive, Room 5211,
Bethesda, MD 20892, schauweckerpe@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Biomedical Sensing, Measurement
and Instrument.
Date: March 9, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Solamar, 435 6th Avenue, San
Diego, CA 92101.
Contact Person: Inna Gorshkova, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, 301–435–1784, gorshkoi@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Aging and Development, Auditory,
Vision and Low Vision Technologies.
Date: March 9–10, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Westgate Hotel, 1055 Second
Avenue, San Diego, CA 92101.
Contact Person: Paek-Gyu Lee, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4201,
MSC 7812, Bethesda, MD 20892, (301) 613–
2064, leepg@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Brain Disorders and Related
Neurosciences.
Date: March 9–10, 2017.
Time: 8:00 a.m. to 5:00 p.m.
VerDate Sep<11>2014
18:11 Feb 08, 2017
Jkt 241001
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Vilen A. Movsesyan,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040M,
MSC 7806, Bethesda, MD 20892, 301–402–
7278, movsesyanv@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Larynx and Voice Disorders.
Date: March 9, 2017.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Unja Hayes, Ph.D.,
Scientific Review Officer, National Institutes
of Health, Center for Scientific Review, 6701
Rockledge Drive, Bethesda, MD 20892, 301–
827–6830, unja.hayes@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR 16–
333: Metabolic Contributions to the
Neurocognitive Complications of Diabetes:
Ancillary Studies (R01).
Date: March 9, 2017.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Hui Chen, MD, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Bethesda, MD 20892, 301–435–1044,
chenhui@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Endocrinology, Metabolism,
Nutrition, and Reproductive Science.
Date: March 10, 2017.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Elaine Sierra-Rivera, Ph.D.,
Scientific Review Officer, EMNR IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6182,
MSC 7892, Bethesda, MD 20892, 301 435–
2514, riverase@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 3, 2017.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–02618 Filed 2–8–17; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
10021
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Minority Health
and Health Disparities; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Minority Health and Health Disparities
Special Emphasis Panel; Internet Assisted
Meeting, ZMD1 XLN M1.
Date: March 13, 2017.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
meeting).
Contact Person: Xinli Nan, Ph.D., Scientific
Review Officer, National Institute on
Minority Health and Health Disparities,
National Institutes of Health, Scientific
Review Branch, OERA, 6707 Democracy
Blvd., Suite 800, Bethesda, MD 20892, (301)
594–7784, Xinli.Nan@nih.gov.
Dated: February 2, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–02614 Filed 2–8–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications/
contract proposals and the discussions
E:\FR\FM\09FEN1.SGM
09FEN1
10022
Federal Register / Vol. 82, No. 26 / Thursday, February 9, 2017 / Notices
sradovich on DSK3GMQ082PROD with NOTICES
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications/
contract proposals, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Questions
in Cancer System Biology.
Date: March 2, 2017.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
2E908, Rockville, MD 20850.
Contact Person: Adriana Stoica, Ph.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W234, Bethesda, MD 20892–9750,
240–276–6368, stoicaa2@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Tools for
Monitoring RNA.
Date: March 14, 2017.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
4W030, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Jeffrey E. DeClue, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W238, Bethesda, MD 20892–
9750, 240–276–6371, decluej@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Co-Clinical
Imaging.
Date: March 30, 2017.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W030, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Kenneth L. Bielat, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W244, Rockville, MD 20892–
9750, 240–276–6373, bielatk@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Collaborative Consortia for the Study of HIVAssociated Cancers (U54) RFA–CA–16–018.
Date: April 5–6, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
North Bethesda, MD 20852.
Contact Person: Adriana Stoica, Ph.D.,
Scientific Review Officer, Resources and
VerDate Sep<11>2014
18:11 Feb 08, 2017
Jkt 241001
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W234, Rockville, MD 20892–9750,
240–276–6368, stoicaa2@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Cancer
Center Support Grant.
Date: April 7, 2017.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W030, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Caterina Bianco, MD,
Ph.D., Scientific Review Officer, Research
Programs Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W110, Bethesda, MD 20892–9750,
240–276–6459, biancoc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: February 3, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–02621 Filed 2–8–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The invention listed below is
owned by an agency of the U.S.
Government and is available for
licensing to achieve expeditious
commercialization of results of
federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
FOR FURTHER INFORMATION CONTACT:
Licensing information and copies of the
patent applications listed below may be
obtained by communicating with the
indicated licensing contact at the
Technology Transfer and Intellectual
Property Office, National Institute of
Allergy and Infectious Diseases, 5601
SUMMARY:
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Fishers Lane, Rockville, MD, 20852; tel.
301–496–2644. A signed Confidential
Disclosure Agreement will be required
to receive copies of unpublished patent
applications.
SUPPLEMENTARY INFORMATION:
Technology description follows.
Small Molecule Imaging of Fungi by
Positron Emission Tomography
Scanning
Description of Technology
This technology relates to the field of
radioactive, isotopically-labeled
calcofluor derivatives and uses of such
compounds to detect a broad spectrum
of filamentous fungi including
pathogenic species such as Aspergillus
and Mucorales, by diagnostic imaging
methods such as positron emission
tomography (PET) scanning.
Aspergillosis and other filamentous
fungal infections are increasingly
common fungal lung infection with high
mortality rates (over 50%) in immune
compromised patients, such as those
receiving chemotherapy, stem cell/organ
transplantation, or HIV patients. Oneyear survival of the infected patients
ranges from 59% (organ transplant
recipients) to as low as 25% (stem cell
transplant recipients). Delayed
diagnosis and therapy are likely to lead
to poor outcomes and death. This
disease is often first detected as nodules
on CT scans. A diagnosis is typically
made following invasive lung
bronchoscopy or biopsy. However, as
these patients are
immunocompromised, these invasive
procedures may themselves lead to
significant complications and
infections. Therefore, to enable timely
treatment and minimize complications,
there is a critical need for non-invasive
means to detect and diagnose fungal
infections.
The calcofluor derivatives disclosed
in the patent application may be
utilized as imaging agents specific for
fungal infections and could potentially
become a standard, non-invasive
procedure in the work-up of
immunocompromised patients with
lung infections.
This technology is available for
licensing for commercial development
in accordance with 35 U.S.C. 209 and 37
CFR part 404, as well as for further
development and evaluation under a
research collaboration.
Potential Commercial Applications
• Diagnostics of Aspergillosis and
other filamentous fungal infections.
Competitive Advantages
• Non-invasive.
E:\FR\FM\09FEN1.SGM
09FEN1
Agencies
[Federal Register Volume 82, Number 26 (Thursday, February 9, 2017)]
[Notices]
[Pages 10021-10022]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-02621]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications/contract proposals and the
discussions
[[Page 10022]]
could disclose confidential trade secrets or commercial property such
as patentable material, and personal information concerning individuals
associated with the grant applications/contract proposals, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Questions in Cancer System Biology.
Date: March 2, 2017.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 2E908, Rockville, MD 20850.
Contact Person: Adriana Stoica, Ph.D., Scientific Review
Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W234, Bethesda, MD 20892-9750, 240-276-6368,
stoicaa2@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Tools for Monitoring RNA.
Date: March 14, 2017.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 4W030, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W238, Bethesda, MD 20892-9750, 240-276-6371,
decluej@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Co-Clinical Imaging.
Date: March 30, 2017.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W030, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Kenneth L. Bielat, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W244, Rockville, MD 20892-9750, 240-276-6373,
bielatk@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Collaborative Consortia for the Study of HIV-Associated
Cancers (U54) RFA-CA-16-018.
Date: April 5-6, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, North Bethesda, MD 20852.
Contact Person: Adriana Stoica, Ph.D., Scientific Review
Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W234, Rockville, MD 20892-9750, 240-276-6368,
stoicaa2@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Cancer Center Support Grant.
Date: April 7, 2017.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W030, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Caterina Bianco, MD, Ph.D., Scientific Review
Officer, Research Programs Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W110, Bethesda, MD 20892-9750, 240-276-6459,
biancoc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: February 3, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-02621 Filed 2-8-17; 8:45 am]
BILLING CODE 4140-01-P